The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cellectar Biosciences Inc’s current trading price is -30.11% away from its 52-week high, while its distance from the 52-week low is 133.83%. The stock’s price range for this period has been between $1.33 and $4.45 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.9 million for the day, a number notably lower than the average daily volume of 1.11 million over the last three months.
Cellectar Biosciences Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $4.45 on 03/04/24 and a low of $1.33 for the same time frame on 05/09/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cellectar Biosciences Inc (CLRB) has experienced a quarterly decline of -15.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 100.33M and boasts a workforce of 20 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.37, with a change in price of +0.88. Similarly, Cellectar Biosciences Inc recorded 1,375,836 in trading volume during the last 100 days, posting a change of +39.46%.
CLRB Stock Stochastic Average
Cellectar Biosciences Inc’s raw stochastic average for the past 50 days is presently 10.07%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 12.61%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 11.11% and 7.27%, respectively.
CLRB Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 12.27%. However, over the past six months, we’ve seen a weaker performance of 18.25%. The price of CLRB leaped by -23.21% over the last 30 days. And in the last five days, it has fallen by -6.04%.
